XRAY
DENTSPLY SIRONA Inc
$
11.180
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
11.250
Open
10.820
VWAP
11.08
Vol
6.02M
Mkt Cap
2.23B
Low
10.690
Amount
66.71M
EV/EBITDA(TTM)
6.90
Total Shares
207.63M
EV
4.26B
EV/OCF(TTM)
19.29
P/S(TTM)
0.61
DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. It develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional-directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for urinary and bowel management.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q2
FY2026Q1
FY2025Q4
942.65M
+0.71%
0.524
+0.74%
905.75M
+3.04%
0.450
+4.54%
930.22M
+2.79%
0.351
+34.88%
Estimates Revision
The market is revising Downward the revenue expectations for DENTSPLY SIRONA Inc. (XRAY) for FY2025, with the revenue forecasts being adjusted by -0.03% over the past three months. During the same period, the stock price has changed by -10.74%.
Revenue Estimates for FY2025
Revise Downward
-0.03%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-0.66%
In Past 3 Month
Stock Price
Go Down
-10.74%
In Past 3 Month
15 Analyst Rating
Wall Street analysts forecast XRAY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XRAY is 15.65 USD with a low forecast of 13.00 USD and a high forecast of 23.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
12 Hold
0 Sell
Hold
Current: 11.180
Low
13.00
Averages
15.65
High
23.00
Current: 11.180
Low
13.00
Averages
15.65
High
23.00
Piper Sandler
Neutral
downgrade
$16 -> $13
2025-11-07
New
Reason
Piper Sandler
Price Target
$16 -> $13
2025-11-07
New
downgrade
Neutral
Reason
Piper Sandler lowered the firm's price target on Dentsply Sirona to $13 from $16 and keeps a Neutral rating on the shares. The firm notes the company reported Q3 results, with revenue finishing just ahead of Street but EBITDA and EPS missed. Guidance was cut across the board, and while in part a formality with investors already anticipating such a move, challenges in the U.S. are larger than originally thought, Piper adds.
Baird
Neutral
downgrade
$18 -> $14
2025-11-07
New
Reason
Baird
Price Target
$18 -> $14
2025-11-07
New
downgrade
Neutral
Reason
Baird lowered the firm's price target on Dentsply Sirona to $14 from $18 and keeps a Neutral rating on the shares. The firm updated its model following Q3 results which provided many updates by low visibility remains.
JPMorgan
Neutral
downgrade
$14 -> $12
2025-11-07
New
Reason
JPMorgan
Price Target
$14 -> $12
2025-11-07
New
downgrade
Neutral
Reason
JPMorgan lowered the firm's price target on Dentsply Sirona to $12 from $14 and keeps a Neutral rating on the shares.
Mizuho
Neutral
downgrade
$16 -> $13
2025-11-07
New
Reason
Mizuho
Price Target
$16 -> $13
2025-11-07
New
downgrade
Neutral
Reason
Mizuho lowered the firm's price target on Dentsply Sirona to $13 from $16 and keeps a Neutral rating on the shares.
Morgan Stanley
Erin Wright
Equal Weight
downgrade
$14 -> $12
2025-11-07
New
Reason
Morgan Stanley
Erin Wright
Price Target
$14 -> $12
2025-11-07
New
downgrade
Equal Weight
Reason
Morgan Stanley analyst Erin Wright lowered the firm's price target on Dentsply Sirona to $12 from $14 and keeps an Equal Weight rating on the shares.
Stifel
Hold
downgrade
$15 -> $13
2025-11-06
New
Reason
Stifel
Price Target
$15 -> $13
2025-11-06
New
downgrade
Hold
Reason
Stifel lowered the firm's price target on Dentsply Sirona to $13 from $15 and keeps a Hold rating on the shares. The Q3 earnings call had more fireworks than expected, the firm says. Management lowered 2025 guidance, and the company will again undergo a new CFO search, as Matt Garth has departed after only 5 months on the job. While the lower 2025 exit rate negatively impacts Stifel's 2026/2027 estimates, new CEO Dan Scavilla talked in detail about his return to growth action plan, which the firm believes may start to pay dividends in the second half of 2026.
See All Ratings
Valuation Metrics
The current forward P/E ratio for DENTSPLY SIRONA Inc (XRAY.O) is 6.35, compared to its 5-year average forward P/E of 16.31. For a more detailed relative valuation and DCF analysis to assess DENTSPLY SIRONA Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Undervalued
5Y Average PE
16.31
Current PE
6.35
Overvalued PE
21.47
Undervalued PE
11.15
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Undervalued
5Y Average EV/EBITDA
12.14
Current EV/EBITDA
6.44
Overvalued EV/EBITDA
15.05
Undervalued EV/EBITDA
9.23
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Strongly Overvalued
5Y Average PS
2.05
Current PS
11.18
Overvalued PS
3.20
Undervalued PS
0.90
Financials
Annual
Quarterly
FY2025Q3
YoY :
-4.94%
904.00M
Total Revenue
FY2025Q3
YoY :
-26.87%
49.00M
Operating Profit
FY2025Q3
YoY :
-13.54%
-428.00M
Net Income after Tax
FY2025Q3
YoY :
-13.01%
-2.14
EPS - Diluted
FY2025Q3
YoY :
-60.20%
39.00M
Free Cash Flow
FY2025Q3
YoY :
-6.28%
48.78
Gross Profit Margin - %
FY2025Q3
YoY :
-76.39%
2.21
FCF Margin - %
FY2025Q3
YoY :
-9.03%
-47.35
Net Margin - %
FY2025Q3
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
1
250.0K
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
4.6M
Volume
1
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
855.3K
Volume
Months
0-12
3
3.0M
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
32.0K
USD
4
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
1
250.0K
USD
Months
0-12
0
0.0
USD
Months
XRAY News & Events
Events Timeline
2025-11-06 (ET)
2025-11-06
08:09:51
Dentsply Sirona announces Q3 adjusted EPS of 37 cents, falling short of consensus estimate of 45 cents.
2025-10-14 (ET)
2025-10-14
18:46:30
Dentsply Sirona announces that the SEC will not pursue any actions against the company.
2025-10-02 (ET)
2025-10-02
08:34:43
Dentsply Sirona Names Denti as Chief Commercial Officer
Sign Up For More Events
Sign Up For More Events
News
6.0
11-07BenzingaWells Fargo Keeps Equal-Weight Rating on Dentsply Sirona, Reduces Price Target to $12
6.0
11-07BenzingaCarMax Analyst Changes Stance; Check Out the Top 5 Downgrades for Friday
9.5
11-06BenzingaDentsply Sirona Shares Plummet After Disappointing Results and Revised 2025 Forecast; CEO Introduces Growth Recovery Strategy
Sign Up For More News
People Also Watch
SHC
Sotera Health Co
15.680
USD
-2.06%
HAE
Haemonetics Corp
68.360
USD
+1.86%
ALIT
Alight Inc
2.350
USD
-1.67%
ATGE
Adtalem Global Education Inc
94.890
USD
-0.26%
SKT
Tanger Inc
34.480
USD
+2.59%
LBRT
Liberty Energy Inc
17.190
USD
-1.21%
APLS
Apellis Pharmaceuticals Inc
19.260
USD
-2.28%
BL
BlackLine Inc
53.580
USD
-5.70%
DXC
DXC Technology Co
13.160
USD
-3.52%
RARE
Ultragenyx Pharmaceutical Inc
30.630
USD
-1.03%
FAQ
What is DENTSPLY SIRONA Inc (XRAY) stock price today?
The current price of XRAY is 11.18 USD — it has increased 1.45 % in the last trading day.
What is DENTSPLY SIRONA Inc (XRAY)'s business?
What is the price predicton of XRAY Stock?
What is DENTSPLY SIRONA Inc (XRAY)'s revenue for the last quarter?
What is DENTSPLY SIRONA Inc (XRAY)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for DENTSPLY SIRONA Inc (XRAY)'s fundamentals?
How many employees does DENTSPLY SIRONA Inc (XRAY). have?